Search by Drug Name or NDC

    NDC 63868-0407-24 Cold and Flu Relief 325; 10; 5 mg/1; mg/1; mg/1 Details

    Cold and Flu Relief 325; 10; 5 mg/1; mg/1; mg/1

    Cold and Flu Relief is a ORAL CAPSULE, LIQUID FILLED in the HUMAN OTC DRUG category. It is labeled and distributed by QUALITY CHOICE (Chain Drug Marketing Association). The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 63868-0407
    Product ID 63868-407_a0d31e7e-9380-4515-bb05-54410d27f3e2
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Cold and Flu Relief
    Proprietary Name Suffix Daytime
    Non-Proprietary Name ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE, LIQUID FILLED
    Route ORAL
    Active Ingredient Strength 325; 10; 5
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name QUALITY CHOICE (Chain Drug Marketing Association)
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through n/a

    Package

    NDC 63868-0407-24 (63868040724)

    NDC Package Code 63868-407-24
    Billing NDC 63868040724
    Package 24 BLISTER PACK in 1 CARTON (63868-407-24) / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
    Marketing Start Date 2018-08-31
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL f4b0ffa6-f517-4305-8569-990f7bc89c3c Details

    Revised: 9/2022